CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 18 enrolled
Drug / intervention
Ketamine +1 moredrug
Likely dose
Ketamine 0.2 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01887990
NCT01887990N/ACompleted
CompareCT.gov

Treatment of Suicidal Ideation With Intravenous Ketamine Infusion

University of Alabama at Birmingham·interventional·Posted Jun 27, 2013·Updated May 15, 2017

In Brief

A clinical study evaluating Ketamine and placebo for Depression and Suicidal Ideation. Completed, enrolled 18 participants across 1 site.

Detailed Summary

This study is dedicated to achieving better treatments for suicidal thoughts. Specifically, the investigators are studying the effect of a medication called ketamine to quickly treat suicidal thoughts and depression.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression, Suicidal Ideation
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJun 27, 2013
Enrollment StartMay 1, 2012
Primary CompletionJan 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 13.0 years ago

Interventions

Ketaminedrug

single dose IV 0.2 mg/kg ketamine

placebodrug

saline infusion